Allergy Immunotherapy for the Reduction of Asthma (AIR)
This study has suspended participant recruitment.
(No evidence of clinically meaningful benefits for asthma (reduction of asthma medication scores and symptoms) in preliminary analysis)
Albert Einstein College of Medicine, Inc.
First Posted: December 9, 2009
Last Update Posted: July 1, 2015
Jacobi Medical Center
Information provided by (Responsible Party):
Gabriele de Vos, Albert Einstein College of Medicine of Yeshiva University
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has suspended participant recruitment.|
|Study Completion Date:||No date given|
|Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
de Vos G, Nazari R, Ferastraoaru D, Parikh P, Geliebter R, Pichardo Y, Wiznia A, Rosenstreich D. Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years. Ann Allergy Asthma Immunol. 2013 Jun;110(6):438-43. doi: 10.1016/j.anai.2013.03.006. Epub 2013 Apr 11.
de Vos G, Shankar V, Nazari R, Kooragayalu S, Smith M, Wiznia A, Rosenstreich D. Fear of repeated injections in children younger than 4 years receiving subcutaneous allergy immunotherapy. Ann Allergy Asthma Immunol. 2012 Dec;109(6):465-9. doi: 10.1016/j.anai.2012.10.003. Erratum in: Ann Allergy Asthma Immunol. 2013 Mar;110(3):216.